Palliative Care for Adults Across the Cancer Trajectory: From Diagnosis to End of Life

Seminars in Oncology Nursing

Volumn 26, Issue 4, 2010, Pages 222-230

  Brant, Jeannine M ^a  

^a BILLINGS CLINIC   (United States)

Author keywords

Cancer trajectory; Palliative care; Symptoms

Indexed keywords

ANTINEOPLASTIC AGENT;

ADAPTIVE BEHAVIOR; ARTICLE; HUMAN; MENTAL STRESS; NEOPLASM; NURSING; ONCOLOGY NURSING; PALLIATIVE THERAPY; PSYCHOLOGICAL ASPECT; RADIOTHERAPY;

ADAPTATION, PSYCHOLOGICAL; ANTINEOPLASTIC AGENTS; HUMANS; NEOPLASMS; ONCOLOGIC NURSING; PALLIATIVE CARE; RADIOTHERAPY; STRESS, PSYCHOLOGICAL;

EID: 77958189257     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soncn.2010.08.002     Document Type: Article

References (54)

1. Cancer Pain Relief and Palliative Care. Report of a WHO Expert Committee 1990, World Health Organization, WHO, Geneva, Switzerland.
2. Degner L.F., Sloan J.A. Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer. J Pain Symptom Manage 1995, 10:423-431.
3. Sheldon L.K., Swanson S., Dolce A., Marsh K., Summers J. Putting evidence into practice: evidence-based interventions for anxiety. Clin J Oncol Nurs 2008, 12:789-797.
4. Surbone A., Baider L., Weitzman T.S., Brames M.J., Rittenberg C.N., Johnson J. Psychosocial care for patients and their families is integral to supportive care in cancer: MASCC position statement. Support Care Cancer 2010, 18:255-263.
5. Berger A.M., Parker K.P., Young-McCaughan S., et al. Sleep wake disturbances in people with cancer and their caregivers: state of the science. Oncol Nurs Forum 2005, 32:E98-E126.
6. Mitchell S.A., Beck S.L., Hood L.E., Moore K., Tanner E.R. Putting evidence into practice: evidence-based interventions for fatigue during and following cancer and its treatment. Clin J Oncol Nurs 2007, 11:99-113.
7. Ip H.Y., Abrishami A., Peng P.W., Wong J., Chung F. Predictors of postoperative pain and analgesic consumption: a qualitative systematic review. Anesthesiology 2009, 111:657-677.
8. Sahai S.K., Zalpour A., Rozner M.A. Preoperative evaluation of the oncology patient. Med Clin North Am 2010, 94:403-419.
9. Wilson T.R., Alexander D.J., Kind P. Measurement of health-related quality of life in the early follow-up of colon and rectal cancer. Dis Colon Rectum 2006, 49:1692-1702.
10. Poage E., Singer M., Armer J., Poundall M., Shellabarger M.J. Demystifying lymphedema: development of the lymphedema putting evidence into practice card. Clin J Oncol Nurs 2008, 12:951-964.
11. Hayes S.C., Janda M., Cornish B., Battistutta D., Newman B. Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol 2008, 26:3536-3542.
12. Yamagishi A., Morita T., Miyashita M., Kimura F. Symptom prevalence and longitudinal follow-up in cancer outpatients receiving chemotherapy. J Pain Symptom Manage 2009, 37:823-830.
13. Honea N., Brant J., Beck S. Treatment-related symptom clusters. Semin Oncol Nurs 2006, 31:142-151.
14. Armstrong T., Almadrones L., Gilbert M.R. Chemotherapy-induced peripheral neuropathy. Oncol Nurs Forum 2005, 32:305-311.
15. Rhee J., Oishi K., Garey J., Kim E. Management of rash and other toxicities in patients treated with epidermal growth factor receptor-targeted agents. Clin Colorectal Cancer 2005, 5(Suppl 2):S101-S106.
16. Chlebowski R.T., Geller M.L. Adherence to endocrine therapy for breast cancer. Oncology 2006, 71:1-9.
17. Hickok J.T., Morrow G.R., Roscoe J.A., Mustian K., Okunieff P. Occurrence, severity, and longitudinal course of twelve common symptoms in 1129 consecutive patients during radiotherapy for cancer. J Pain Symptom Manage 2005, 30:433-442.
18. Fletcher B.S., Paul S.M., Dodd M.J., et al. Prevalence, severity, and impact of symptoms on female family caregivers of patients at the initiation of radiation therapy for prostate cancer. J Clin Oncol 2008, 26:599-605.
19. Qadeer M.A., Vargo J.J. Approaches to the prevention and management of radiation colitis. Curr Gastroenterol Rep 2008, 10:507-513.
20. Fulcher C.D., Badger T., Gunter A.K., Marrs J.A., Reese J.M. Putting evidence into practice: interventions for depression. Clin J Oncol Nurs 2008, 12:131-140.
21. Stein K.D., Syrjala K.L., Andrykowski M.A. Physical and psychological long-term and late effects of cancer. Cancer 2008, 112(11 Suppl):2577-2592.
22. Institute of Medicine. From Cancer Patient to Cancer Survivor: Lost in Transition. Available at: Accessed Jan. 18, 2010. http://www.nap.edu/catalog/11468.html.
23. Perkins F.M., Kehlet H. Chronic pain as an outcome of surgery. Anesthesiology 2000, 93:1123-1133.
24. Polomano R.C., Farrar J.T. Pain and neuropathy in cancer survivors. Cancer Nurs 2006, 29(2 Suppl):39-47.
25. Cavaletti G. Peripheral neurotoxicity of platinum-based chemotherapy. Nat Rev Cancer 2008, 8. 1p following 71.
26. Cavaletti G., Bogliun G., Marzorati L., et al. Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy. Ann Oncol 2004, 15:1439-1442.
27. Land S.R., Kopec J.A., Cecchini R.S., et al. Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07. J Clin Oncol 2007, 25:2205-2211.
28. Schneider E.C., Malin J.L., Kahn K.L., Ko C.Y., Adams J., Epstein A.M. Surviving colorectal cancer: patient-reported symptoms 4 years after diagnosis. Cancer 2007, 110:2075-2082.
29. Badin S., Iqbal A., Sikder M., Chang V.T. Persistent pain in anal cancer survivors. J Cancer Surviv 2008, 2:79-83.
30. Ream E. Fatigue in patients receiving palliative care. Nurs Stand 2007, 21:49-56. quiz 58.
31. Morrison L.J., Morrison R.S. Palliative care and pain management. Med Clin North Am 2006, 90:983-1004.
32. Patrick D.L., Ferketich S.L., Frame P.S., et al. National Institutes of Health State-of-the-Science Conference Statement: symptom management in cancer: pain, depression, and fatigue, July 15-17, 2002. J Natl Cancer Inst Monogr 2004, 32:9-16.
33. Fortner B., Okon T., Ashley J., et al. The zero acceptance of pain (ZAP) quality improvement project: evaluation of pain severity, pain interference, global quality of life, and pain-related costs. J Pain Symptom Manage 2003, 25:334-343.
34. Fortner B., Okon T., Schwartzberg L., Tauer K., Houts A. The cancer care monitor: Psychometric content evaluation and pilot testing of a computer administered system for symptom screening and quality of life in adult cancer patients. J Pain Symptom Manage 2003, 26:1077-1092.
35. Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain 2008, American Pain Society, APS Press, Glenview, IL. 6th ed.
36. National Comprehensive Cancer Network. Clinical Practice Guidelines. In: Network NCC, ed; 2010. Available at: Accessed June 1, 2010. http://www.nccn.org/index.asp.
37. Oncology Nursing Society. Putting Evidence into Practice; 2007. Available at: Accessed June 4, 2010. http://ons.org/Research/PEP/Topics.
38. Adams L.A., Shepard N., Caruso R.A., Norling M.J., Belansky H., Cunningham R.S. Putting evidence into practice: evidence-based interventions to prevent and manage anorexia. Clin J Oncol Nurs 2009, 13:95-102.
39. Clary P.L., Lawson P. Pharmacologic pearls for end-of-life care. Am Fam Physician 2009, 79:1059-1065.
40. Guay D.R. Methylnaltrexone methobromide: the first peripherally active, centrally inactive opioid receptor-antagonist. Consult Pharm 2009, 24:210-226.
41. Vella-Brincat J., Macleod A.D. Adverse effects of opioids on the central nervous systems of palliative care patients. J Pain Palliat Care Pharmacother 2007, 21:15-25.
42. Palos G.R. Opioids and cancer survivors: issues in side-effect management. Oncol Nurs Forum 2008, 35(Suppl):13-19.
43. Lynch T.J., Kim E.S., Eaby B., Garey J., West D.P., Lacouture M.E. Epidermal growth factor receptor inhibitor-associated cutaneous toxicities: an evolving paradigm in clinical management. Oncologist 2007, 12:610-621.
44. Muehlbauer P.M., Thorpe D., Davis A., Drabot R., Rawlings B.L., Kiker E. Putting evidence into practice: evidence-based interventions to prevent, manage, and treat chemotherapy- and radiotherapy-induced diarrhea. Clin J Oncol Nurs 2009, 13:336-341.
45. Qaseem A., Snow V., Shekelle P., et al. Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2008, 148:141-146.
46. Lymphedema FAQs National Lymphedema Network, Available at, Accessed June 20, 2010. http://www.lymphnet.org/lymphedemaFAQs/overview.htm.
47. Harris D.J., Eilers J., Harriman A., Cashavelly B.J., Maxwell C. Putting evidence into practice: evidence-based interventions for the management of oral mucositis. Clin J Oncol Nurs 2008, 12:141-152.
48. Keefe D.M., Schubert M.M., Elting L.S., et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 2007, 109:820-831.
49. Tipton J.M., McDaniel R.W., Barbour L., et al. Putting evidence into practice: evidence-based interventions to prevent, manage, and treat chemotherapy-induced nausea and vomiting. Clin J Oncol Nurs 2007, 11:69-78.
50. Aiello-Laws L., Reynolds J., Deizer N., Peterson M., Ameringer S., Bakitas M. Putting evidence into practice: what are the pharmacologic interventions for nociceptive and neuropathic cancer pain in adults?. Clin J Oncol Nurs 2009, 13:649-655.
51. Page M.S., Berger A.M., Johnson L.B. Putting evidence into practice: evidence-based interventions for sleep-wake disturbances. Clin J Oncol Nurs 2006, 10:753-767.
52. Tschoppe P., Wolgin M., Pischon N., Kielbassa A.M. Etiologic factors of hyposalivation and consequences for oral health. Quintessence Int 2010, 41:321-333.
53. Hahnel S., Behr M., Handel G., Burgers R. Saliva substitutes for the treatment of radiation-induced xerostomia-a review. Support Care Cancer 2009, 17:1331-1343.
54. Bhide S.A., Miah A.B., Harrington K.J., Newbold K.L., Nutting C.M. Radiation-induced xerostomia: pathophysiology, prevention and treatment. Clin Oncol (R Coll Radiol) 2009, 21:737-744.